Global EPA and DHA Market (2021-2026) – Growth, Trends, COVID-19 Impact, and Forecast

DUBLIN, November 03, 2021– (BUSINESS WIRE) – The report “EPA & DHA Market – Growth, Trends, COVID-19 Impact and Forecast (2021 – 2026)” has been added to ResearchAndMarkets.com offer.

The global EPA and DHA market is expected to grow at the CAGR of 8.26% during the forecast period (2021 – 2026).

Companies mentioned

  • Koninklijke DSM NV

  • The Archer Daniels Midland Company

  • Corbion SA

  • Neptune wellness solutions

  • BASF SE

  • Croda International SA

  • Pelagia AS

  • Golden Omega SA

  • Arctic nutrition

  • Wiley Companies (Organic Technology)

Key market trends

Docosahexaenoic Acid (DHA) Has Dominated The Market By Type

The DHA segment is mainly driven by the increasing demand and its incorporation into infant formula and nutritional products targeting children’s health, as it is an essential part of the growth and maturation of the brain and the retina of an infant. It is mainly obtained from fish oils and seaweed. Additionally, it is widely used in fortified foods and dietary supplements, where it is primarily used to treat type 2 diabetes, coronary heart disease (CAD), dementia, and attention deficit hyperactivity disorder (ADHD). ). The healthy aging benefits of DHA have also led to their successful use in geriatric nutrition products. In addition, an increasing number of product launches around the world are promoting the growth of the industry. For example, Organic Technologies, in 2017, launched two new DHA omega-3 concentrates in its AlaskOmega line of fish oils and concentrates – a high DHA concentrate and an alternative to DHA tuna oil (no. tuna) of medium strength.

North America dominated the EPA and DHA market

The North American market for EPA and DHA ingredients is primarily driven by innovation, both in products and in technology. Major players are investing in technological advancements in order to develop improved omega ingredients for wider applications. In October 2016, DSM launched a new process technology, 3C technology. The technology helps omega-3 manufacturers produce highly concentrated ingredients (up to 85%). It also allows manufacturers to customize combinations of EPA and DHA for application in pharmaceutical and dietary supplements. The trend towards consuming supplements instead of functional foods is predominant in the region. Consumers prefer highly concentrated dietary supplements to meet their nutritional needs for DHA / EPA. Thus, stimulate the growth of the ingredients sector in the region.

Main topics covered:

1. INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market drivers

4.2 Market constraints

4.3 Porter’s five forces analysis

5 MARKET SEGMENTATION

5.1 By type

5.1.1 Eicosapentaenoic acid (EPA)

5.1.2 Docosahexaenoic acid (DHA

5.2 By source

5.2.1 Fish oil

5.2.2 Seaweed oil

5.2.3 Krill oil

5.2.4 Other sources

5.3 By application

5.3.1 Infant Formula

5.3.2 Food supplements

5.3.3 Fortified Foods and Beverages

5.3.4 Pharmaceuticals

5.3.5 Other applications

5.4 By geography

6 COMPETITIVE LANDSCAPE

6.1 Most active companies

6.2 Most adopted strategies

6.3 Market share analysis

6.4 Company profiles

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

8 IMPACT OF COVID-19 ON THE MARKET

For more information on this report, visit https://www.researchandmarkets.com/r/qzaequ

See the source version on businesswire.com: https://www.businesswire.com/news/home/20211103006064/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Director
[email protected]

For EST office hours, call 1-917-300-0470
For USA / CAN call toll free 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

About Dianne Stinson

Check Also

Global Platelet Level Packaging Market (2021-2026)

DUBLIN, November 26, 2021 / PRNewswire / – The “Platelet Level Packaging Market: Global Industry …

Leave a Reply

Your email address will not be published. Required fields are marked *